USPTO serial 97041123
DO THE AMAZING
Reviewed by CopyMark Law Group
Status 732Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCCAULEY, BRENDAN D
- Law office
- TMO LAW OFFICE 137
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with DO THE AMAZING?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $648*
Plus Government fees of $300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
King of Prussia, PA, US
King of Prussia, PA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 THOMAS JEFFERSON STREET, NWSUITE 400WASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Promoting awareness of life saving blood plasma donation; Promoting awareness of blood diseases, illnesses and conditions; Promoting awareness of vaccines and related illnesses; Promoting the donation of blood plasma by means of arranging and conducting incentive reward and blood plasma donor loyalty programs; Business administration of an incentive reward and blood plasma donor loyalty program to promote blood plasma collection services and collection of blood plasma; Promoting public awareness of blood disorders, treatment and impact on patients | ACTIVE | — |
| 044 | Medical services; Medical information services; Medical testing of human blood plasma; Medical testing and screening services for diagnostic or treatment purposes; Medical testing and screening services for blood-borne viruses including serology tests and nucleic acid amplification technology/polymerase chain reaction tests; Medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; Medical diagnostic testing, monitoring and reporting services; Providing medical information and treatment information in the field of health; Health care information services; Healthcare and healthcare information services, namely, providing healthcare information concerning patient lifestyle and wellness for patients, caregivers, parents, teachers, coaches and friends impacted by immunoglobulin, immunodeficiency and neurological disorders; Healthcare, namely, providing health care information in person, via the internet, and through the distribution of printed matter; Healthcare and healthcare information services, namely, providing healthcare information concerning blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; Collection, processing and testing of human blood and plasma for medical purposes; Providing a website featuring medical and healthcare information in the fields of immunoglobulin, immunodeficiency and neurological disorders, and corresponding treatments; Providing a website featuring medical and healthcare information in the fields of health, blood, bleeding conditions, and corresponding treatments; Providing a website featuring healthcare information in the field of the diagnosis and treatment of blood conditions; Providing links to the web sites of others featuring medical and healthcare information about the diagnosis and treatment of immunoglobulin, immunodeficiency and neurological disorders, blood conditions and treatments; Blood bank services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 7, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 7, 2026 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jul 6, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 6, 2026 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Jul 6, 2026 | EXT3 | SOU EXTENSION 3 FILED | — |
| Jul 6, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 14, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 4, 2026 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Feb 4, 2026 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 4, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 7, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 7, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jul 7, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jul 7, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 4, 2025 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 4, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 12, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 16, 2024 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 16, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 19, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| May 17, 2023 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Nov 14, 2022 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 14, 2022 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 14, 2022 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 10, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 10, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 10, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 29, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 22, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 25, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |